Henry Schein Trims Board Size After Longtime Chairman's Retirement
Event summary
- Henry Schein will reduce its board from 15 to 10 members following its May 21, 2026 annual meeting.
- Stanley M. Bergman retires after 44 years as a director and will become Chairman Emeritus.
- Four directors (Joseph L. Herring, Robert J. Hombach, Scott Serota, Bradley T. Sheares) will not stand for reelection.
- Fred Lowery is positioned to lead the company into its next chapter.
The big picture
Henry Schein's board reduction follows Stanley Bergman's retirement after 44 years, marking a significant leadership transition for the healthcare solutions provider. The move reflects broader trends in corporate governance where companies are streamlining boards to improve efficiency. With $13.2 billion in sales in 2025 and operations in 34 countries, the company's strategic direction under new leadership will be closely watched.
What we're watching
- Leadership Continuity
- How Fred Lowery will navigate the transition from Bergman's long tenure and maintain strategic direction.
- Board Composition
- Whether the reduced board size will enhance decision-making agility or limit diverse perspectives.
- Strategic Partnerships
- The impact of the Strategic Partnership Agreement with KKR Hawaii Aggregator L.P. on future growth initiatives.